Page last updated: 2024-09-04

10-propargyl-10-deazaaminopterin and enalaprilat anhydrous

10-propargyl-10-deazaaminopterin has been researched along with enalaprilat anhydrous in 1 studies

Compound Research Comparison

Studies
(10-propargyl-10-deazaaminopterin)
Trials
(10-propargyl-10-deazaaminopterin)
Recent Studies (post-2010)
(10-propargyl-10-deazaaminopterin)
Studies
(enalaprilat anhydrous)
Trials
(enalaprilat anhydrous)
Recent Studies (post-2010) (enalaprilat anhydrous)
119218584610976

Protein Interaction Comparison

ProteinTaxonomy10-propargyl-10-deazaaminopterin (IC50)enalaprilat anhydrous (IC50)
Angiotensin-converting enzymeMus musculus (house mouse)0.0115
Angiotensin-converting enzyme Homo sapiens (human)0.2405
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.0054
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0012
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.0036
Angiotensin-converting enzyme 2 Homo sapiens (human)0.0024

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for 10-propargyl-10-deazaaminopterin and enalaprilat anhydrous

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016